Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl-2 pathway

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant tumor type, and epigenetic modifications such as acetylation or deacetylation serve vital roles in its development. Chidamide, a novel histone deacetylase inhibitor, exerts an anticancer effect against various types of cancer....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Med Rep
Egile Nagusiak: Zhang, Hongwei, Chi, Fenqing, Qin, Keru, Mu, Xiuli, Wang, Lieyang, Yang, Bin, Wang, Yanli, Bai, Min, Li, Zhenhua, Su, Liping, Yu, Baofeng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2021
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7974270/
https://ncbi.nlm.nih.gov/pubmed/33649847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2021.11947
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak